エピソード

  • TMO Today - Aug 13: Mixed Signals from Investors

    TMO Today - Aug 13: Mixed Signals from Investors
    2026/08/13
    Hey there! It's Joey here, your friendly longtime investor breaking down the day. Today, we’re talking about Thermo Fisher Scientific, and it was a bit of a red day for them. They dipped just a tiny bit, down 0.17%.

    So, what went down? Honestly, it was a pretty quiet day overall. The trading volume was right on average, so not much frenzy happening. It seems investors were a bit split on their feelings about TMO. Some folks decided to cut back on their shares, like Y Intercept and Howland Capital, while others, like Magellan Asset Management, jumped in and added more to their positions. Kind of a mixed bag, you know?

    Now, why the mixed signals? Well, there’s buzz around Thermo Fisher’s recent Q2 earnings where they beat estimates by a whopping $300 million. That’s a big win! But then you’ve got the sale of their microbiology unit to Astorg, which is a major shift for the company. Some investors are probably feeling a little uncertain about how that’ll play out. So, it’s like one step forward, one step back.

    Also, there’s chatter about their stock position changes. Some are scaling back, and others are upping their game. It's interesting to see how different investors are reading the tea leaves on this one.

    Looking ahead, Thermo Fisher recently closed that sale of the microbiology unit, which is a big deal. It could mean a whole new direction for them, and investors are definitely keeping an eye on what that means for the future.

    So, that’s the scoop for today! Thermo Fisher is navigating some ups and downs, and it’s clear folks are weighing their options. Remember, I'm just sharing info and having a good time talking stocks, so take this as entertainment and not financial advice. Catch you later!
    続きを読む 一部表示
    2 分
  • TMO Today - Aug 12: FDA news and insider selling

    TMO Today - Aug 12: FDA news and insider selling
    2026/08/12
    Hey there! It’s Joey, your friendly longtime investor, here to break down today’s action on Thermo Fisher Scientific, or TMO for short. Today was a bit of a bummer—it ended in the red, down about 1.3%.

    So, what happened? The stock got hit with a small drop, losing a bit of its value. Not a huge shakeup, but still, nobody likes to see their stocks go down, right? The volume was pretty standard, so it wasn’t like a panic sell-off or anything wild.

    Now, why did this happen? Well, there’s a mix of stuff going on. First off, there was some chatter about a new FDA-cleared platform for treating multiple myeloma. Sounds fancy, right? But it seems like investors are still trying to process what that actually means for the company long-term. Mixed reactions are always a thing in the market, and this one’s no exception.

    On top of that, we had some insider selling today. The VP of Thermo Fisher sold around $245K worth of stock, and the CEO also exercised some options and sold almost 5,000 shares. It’s like, when the big dogs are cashing in, it raises a few eyebrows. People might think, “Do they know something we don’t?” It’s not always a bad sign, but it definitely makes folks a bit uneasy.

    Also, on the buying side, Hudson Value Partners and Northside Capital Management both made moves to grab more shares of TMO. So, it’s not all doom and gloom—there’s still interest in the stock.

    Looking ahead, it’s worth keeping an eye on how that FDA news plays out. If the new platform gains traction, it could turn things around. But for now, it’s a bit of a waiting game.

    Alright, that’s the scoop on TMO today. Just remember, I’m here to share info and keep it real—not giving any financial advice. Catch you later!
    続きを読む 一部表示
    2 分
  • TMO Today - Aug 11: Mixed Reactions to FDA News

    TMO Today - Aug 11: Mixed Reactions to FDA News
    2026/08/11
    Hey there! It’s Joey here, your friendly longtime investor, breaking down the day for you. Today, we’re looking at Thermo Fisher Scientific, or TMO for short. It was kind of a mixed bag day, finishing just a smidge in the green, up a tiny 0.15%.

    So, what went down? Well, TMO barely moved, but there were some interesting things happening behind the scenes. The stock saw a bit of action with some big names selling off shares. The CEO, Marc Casper, sold a chunk of his stock—over 4,600 shares, which is a big deal. I mean, when the top dog is cashing out, it can raise some eyebrows, right? Then there’s Handelsbanken Fonder AB cutting back on their holdings too. Not exactly the confidence boost you want to see.

    But here’s where it gets interesting: Investors were buzzing about a new FDA clearance for TMO’s multiple myeloma platform. This is a major deal in the biotech world, and you’d think that would send the stock soaring. But instead, it felt like people were still weighing the news against those sell-offs. So, we got this weird vibe of excitement mixed with caution. That one stung a bit for some.

    Looking ahead, TMO’s got a lot on its plate, especially with the new product launch coming soon. It'll be interesting to see how that plays out and if it gets people feeling more positive about the stock.

    Alright, that’s the scoop for today! Just remember, this is all for your info and entertainment—no financial advice here. Catch you later!
    続きを読む 一部表示
    1 分
  • TMO Today - Aug 10: Small Move, Big Questions

    TMO Today - Aug 10: Small Move, Big Questions
    2026/08/10
    Hey there! It’s Joey here, your friendly longtime investor, breaking down the day for Thermo Fisher Scientific, ticker TMO. So, today was a bit of a snooze, with the stock barely moving, just up a tiny fraction.

    Honestly, it got a little lost in the shuffle today, barely making waves. We're talking about a change of just 0.05%. Not exactly fireworks, right? It seems like the market was just kind of chillin', and TMO didn’t have much to spark excitement. Volume was pretty standard, so no wild trading action either.

    Now, why the ho-hum day? Well, it looks like investors are still trying to figure out where TMO stands compared to its competitors, especially Danaher. There’s been chatter about which life sciences stock is better positioned, and that kind of talk can make folks hesitant to jump in. Plus, there’s some buzz around TMO’s recent diagnostics momentum. They’re showing some solid growth, but the question on everyone’s mind is whether that growth is already baked into the price. You know how it goes—if everyone thinks the stock's already priced high, they might hold off on buying.

    And here’s something interesting: TMO is targeting over 15% growth in their customer base in India. That’s a big move! It shows they’re looking to expand and tap into new markets, which could be a game changer down the line.

    So, yeah, today was a bit of a slow bleed for TMO, but there are definitely some exciting things happening behind the scenes. Just keep an eye on how they navigate their competition and those growth targets.

    Alright, that's a wrap for today! Remember, this is all for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    2 分
  • TMO Today - Aug 09: CEO Stock Sales

    TMO Today - Aug 09: CEO Stock Sales
    2026/08/09
    Hey there! It’s Joey, your friendly investor buddy, here to break down the day. Today we’re talking about Thermo Fisher Scientific, or TMO for short. It was a green day, up about 2.4%. Not too shabby!

    So, what went down? TMO saw a nice little bump today, and honestly, it seems like folks were feeling pretty optimistic. Even with some big names selling off shares, the stock held its ground. Always interesting to see that kind of resilience, right?

    Now, why the good vibes? Well, there’s some chatter about TMO showing strong momentum in their diagnostics sector. They’ve been pushing hard on that front, and it looks like investors are catching on. But here’s the kicker: some analysts are wondering if the stock’s current valuation already reflects that growth. So, there’s a bit of a debate going on, but it’s clear people are still excited about what TMO can do.

    On the flip side, we have some news that might have raised eyebrows. The CEO, Marc Casper, just sold a hefty chunk of his shares for about $8.6 million. Yeah, that one stung a bit for some investors. When the big boss sells, it can make you wonder what's really going on behind the scenes. But hey, it’s not uncommon for execs to cash in, so it might not be as dramatic as it seems.

    Looking ahead, keep an eye on how TMO continues to perform in the diagnostics space. They’ve been making waves, and it’ll be interesting to see if they can keep that momentum going.

    Alright, that’s a wrap for today! Just remember, I’m here to share info and have a good time talking stocks, not giving financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • TMO Today - Aug 08: CEO Sells Stock

    TMO Today - Aug 08: CEO Sells Stock
    2026/08/08
    Hey there! It’s Joey, your friendly longtime investor, here to break down what went down with Thermo Fisher Scientific today. So, TMO had a pretty solid day, up about 2.4%. Not too shabby, right?

    So, here’s the scoop. The stock jumped after a bit of a slow bleed in the last few sessions. It seems like investors are feeling a little more optimistic today. The volume was right on point, keeping pace with what we usually see.

    Now, why the uptick? Well, it looks like the market's reacting to some insider moves. The CEO, Marc Casper, sold off a chunk of his shares, around $8.6 million worth. Yeah, that one stung for some folks, but it didn’t seem to scare everyone off. Sometimes, when big shots sell, it can raise eyebrows, but it looks like people are shrugging it off this time. Plus, Rockland Trust recently upped their stake in TMO, holding over $32 million. That probably gave some investors a little boost of confidence.

    On top of that, Thermo Fisher’s HR chief also sold some shares after exercising options. That’s not unusual, but when you see multiple insiders selling, it can make you wonder what's brewing behind the scenes. But hey, not everyone’s sweating it.

    One thing to keep an eye on? Thermo Fisher is still a major player in the life sciences and healthcare sectors. As we move into the next quarter, there’s chatter about their upcoming earnings report. That could shake things up a bit, so it’s something to think about.

    Alright, that’s a wrap for today! TMO's looking pretty good as it bounces back, but remember, this is just for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    2 分
  • TMO Today - Aug 07: Guidance Raise Sparks Interest

    TMO Today - Aug 07: Guidance Raise Sparks Interest
    2026/08/07
    Hey, what’s up? It’s Joey here, your friendly investor buddy, breaking down the day for you. So, let’s talk about Thermo Fisher Scientific, or TMO for short. Today was a pretty chill day, with the stock up just under one percent.

    Now, here’s the scoop. TMO clawed back a bit after a rough patch recently. Just last month, it took a nasty dive—like, 31% down, yikes! But today, it managed to creep back up. Seems like some positive vibes are coming from a guidance raise. Basically, they’re feeling optimistic about their future performance, and that’s got some folks feeling a bit better about the stock.

    But it wasn’t all sunshine and rainbows. There was also news about an officer wanting to sell a chunk of shares—like 8.65 million worth. Yeah, that one stung a bit. When insiders sell, it can freak people out, making them think maybe something’s off. But hey, it’s not unusual for insiders to cash in every now and then.

    Now, what’s really interesting is the buzz around their new EXENT Myeloma platform. People are curious if that, along with their recent Q2 results, could change the game for their diagnostics segment. It’s like they’re trying to shift the narrative a bit, and that’s got investors watching closely.

    So, just a heads up, keep an eye on how that new platform rolls out. It could be a big deal for them moving forward.

    Alright, that’s the lowdown for today. Just remember, I’m here to share what’s happening, not to give you financial advice. Always do your own research, folks. Catch you later!
    続きを読む 一部表示
    1 分
  • TMO Today - Aug 06: Slight Dip in Stock Price

    TMO Today - Aug 06: Slight Dip in Stock Price
    2026/08/06
    Hey there! It's Joey, your friendly stock enthusiast, here to break down what's been going on with Thermo Fisher Scientific, or TMO for short. Today was a bit of a red day for TMO, with the stock slipping down by about three-quarters of a percent. Yeah, that one stung a little.

    So, what happened? TMO started the day strong but ended up falling back a bit. It looked like it was just a slow bleed as the day went on, with some folks hitting the sell button. Nothing too dramatic, but definitely not the vibe we like to see.

    Now, why did this happen? Well, the articles floating around don’t point to anything super specific. There was some chatter about other companies out there, like Corning, underperforming, which might’ve influenced the mood. But honestly? Nobody really knows why TMO took a dip today. Sometimes stocks just do their own thing, you know?

    One thing to keep in mind is that Stifel still has a buy rating on TMO and even raised the target price to $650. That’s a good sign for the long haul, even if today wasn’t the best day.

    To wrap it up, TMO had a bit of a rough day, but it’s a long game. Stocks go up and down, and it’s all part of the ride. Just remember, this is all for info and fun, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分